Skip to main content
Treating multi drug resistant TB and HIV/AIDS in Manipur, India

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines.

During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in developed countries, remarkable progress was being made in the field of health. Two decades on, medicines in developing countries are still either too expensive, aren't suitable to be used in many of the contexts in which we work (for example, in hot, humid conditions or where there's a lack of electricity), or simply don't exist for the diseases we need to treat.

In 1999, we launched the Campaign for Access to Essential Medicines, now known as the Access Campaign. Its mission focuses on three areas: overcoming barriers to access to essential medicines, stimulating research and development for neglected diseases, promoting health exceptions to global trade agreements.

In 2003, MSF joined several research institutes, including the Institut Pasteur, to create the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organisation engaged in research and development of new treatments for neglected diseases.

 
Website

MSF Access Campaign

msfaccess.org
 
Treating multi drug resistant TB and HIV/AIDS in Manipur, India
India

MSF urges PM to resist US patent pressure

Press Release 26 Sep 2014
 
Tsholotsho. Community ART Groups (CAG)
Zimbabwe

Community ART groups lighten the load for HIV patients

Project Update 22 Sep 2014
 
Viral Load
HIV/AIDS

High prices hinder access to newer HIV drugs and optimal tests that ensure treatment is working

Press Release 21 Jul 2014
 
Cameroon - Buruli Ulcer sensitization week
Cameroon

"We're in the process of writing a page of medical history"

Voices from the Field 14 Jul 2014
 
Maban, South Sudan
War and conflict

Where is everyone?

Report 6 Jul 2014
 
Journal article

Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programmes

1 Jul 2014
Journal article
 
Siyabulela Qwaka, XDR TB Survivor
Tuberculosis

More MSF patients with DR-TB gain access to dramatically cheaper version of life-saving drug

Press Release 1 Jul 2014
 
Journal article

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

25 Jun 2014
Journal article
 
Journal article

MSF and the aid system: Choosing not to choose

25 Jun 2014
Journal article
Up Next
30 August 2019